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Surgical treatment of nonaneurysmal aortic arch
lesions in patients with systemic embolization
Yann Goue¨ffic, MD,a Philippe Chaillou, MD,a J. Christophe Pillet, MD,a Daniel Duveau, MD,b and
Philippe Patra, MD,a Nantes, France
Purpose: Atherosclerotic lesions of the aortic arch are potential sources of arterial embolism. Here we investigate whether
surgery, with the necessary circulatory supports, can be proposed as a good option for treatment of this problem. Study
of these lesions on a national scale in France has made possible the assessment for future indications of techniques and
results of the surgical management of aortic arch lesions, which retrospectively proved to be embolic.
Methods: Thirty-eight patients, (19 men and 19 women) underwent surgery between 1976 and 1996 in 17 French
cardiovascular surgical centers. The average age at the time of surgery was 49  12 years (range, 31 to 82 years).
Atherosclerotic lesions were detected with transesophagial echocardiography (n  19), angiography of the aortic arch
(n 16), computed tomography (n 9), and magnetic resonance imaging (n 10). Surgery consisted of thrombectomy
and endarterectomy (n  22), aortic resection and graft replacement (n  10), and patch aortoplasty (n  5; one
thrombus disappeared spontaneously before surgery was performed).
Results: The average postoperative period was 30 months (range, 3 to 82 months). Contact was lost with four patients
after a follow-up period of 12 months. On pathologic specimens obtained at surgery, an atherosclerotic plaque was found
in 73% of the cases (n  28). In 15% of the cases, the aorta appeared normal (n  6) and four other types of lesion were
identified: angiosarcoma (n 1), ectasia at the insertion of the remains of the ductus arteriosus (n 1), rupture of tunica
intima (n  1), and a fibroblastic plaque (n  1). A thrombus was identified in 26 cases, attached to the arterial wall in
18 cases. When transesophagial echocardiographic results showed mobile lesions (n  22), histopathologic examination
of specimens allowed the detection of a thrombus in 18 cases and an atherosclerotic plaque with a mobile projection in
four cases. The postoperative mortality rate was 2.6%. The morbidity rate (28.9%; n  11) was related to neurologic
complications (n  6), vascular complications (n  4), and infection (n  1). Four cases (12%) were reoperated.
Conclusion: Nonaneurysmal aortic arch lesions are a frequent and still underestimated source of stroke and peripheral
embolization. Surgery with circulatory support can be recommended in good operative candidates with recurrent critical
events despite medical management and with high embolic potential (young patients with no calcified plaques). (J Vasc
Surg 2002;36:1186-93.)
Transesophagial echocardiography (TEE) has been
particularly fruitful in the assessment of embolic sources,
showing frequent lesions in the aortic arch. Other reports
have also established that the embolic risk of these lesions is
identical to that of atherosclerotic carotid stenosis.1,2 Post
mortem examinations confirm frequent thrombi located on
the aortic arch, attached to these lesions.3 Few patients with
such lesions have undergone surgery, either because the
responsibility of the lesions in the embolic event was not
established or simply because the operative risk was consid-
ered to be too high. In addition, the proper strategy for
management of patients with nonaneurysmal lesions of the
aortic arch with systemic embolization is not yet well estab-
lished. We performed a nationwide study involving the
main vascular and cardiothoracic surgical centers in France
and made possible the assessment of techniques and results
of the surgical management of aortic arch lesions that were
retrospectively proved to be embolic.
METHODS
This retrospective study involved 17 French cardiovas-
cular surgical centers. A questionnaire was sent to all sur-
geons for collection of data. Between 1976 and 1996, 38
patients (19 male and 19 female) underwent surgery (Table
I). The average age of the patients was 49  12 years
(range, 31 to 82 years). In all cases, symptoms were related
to an embolic event (Table I). In 17 cases (44.7%), the
embolic accident reoccurred before surgery. Various spe-
cialists in each center assessed neurologic events.
Detection of aortic arch lesions and their identification
as potential sources of embolic events were conducted with
one or more of the following types of investigation: TEE
(n  19), angiography of the aortic arch and its collaterals
(n  16), computed tomography (n  9), or magnetic
resonance imaging (n  10). In seven cases, TEE was
sufficient to confirm aortic arch lesions causing the symp-
toms. In the other cases, at least two imaging processes
were necessary to complement available etiologic and to-
pographic data for the appropriate therapeutic decision.
The most frequently used method for the assessment of
embolic origin was a combination of TEE and angiography
(n 16). No embolic consequences were induced with the
From the Department of Vascular Surgerya and the Department of Thoracic
and Cardiovascular Surgery,b Guillaume et Rene´ Lae¨nnec Hospital.
Competition of interest: nil.
Reprint requests: Yann Goue¨ffic, MD, Departement of Vascular Surgery,
Hoˆpital Guillaume et Rene´ Lae¨nnec, Bd J Monod St Herblain, 44093
Nantes ce´dex 1, France (e-mail: philippe.patra@chu-nantes.fr).
Copyright © 2002 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2002/$35.00  0 24/1/128933
doi:10.1067/mva.2002.128933
1186
16 angiographic procedures performed. These procedures
allowed identification of the precise location, thickness, and
morphology (sessile, protruding, or mobile) of the plaque
and determination of the existence of a thrombus or calci-
fication.
For clarification of the topographic aspects, we used the
classification of Dubost, Guilmet, and Soyer4 for the surgi-
cal anatomy of the aortic arch (Fig). Patients were divided
into two groups. Group I consisted of 15 patients with
lesions located on segment 1 or 2 of the aorta, up to and
including the ostium of the left common carotid artery, and
group II consisted of 23 patients with lesions located on the
remaining part of segment 2, which included the origin of
the left subclavian artery, and on the proximal part of
segment 3. In group I, the aorta was exposed through a
midline sternotomy for 10 patients, whereas left postero-
lateral thoracic exposure was preferred in the five remaining
patients. Clamping of the aortic arch was performed with
complete circulatory arrest in all but one patient. This
patient had the particularity of an atherosclerotic plaque
involving the ostium of the brachiocephalic artery with an
extension to the aortic arch. Lateral aortic clamping was
necessary with a permanent aorta–right carotid artery and
right subclavian artery bypass graft. Several procedures
were used to protect the brain during circulatory arrest:
profound hypothermia (alone; n  8), retrograde cere-
broplegia (n  2), anterograde cerebroplegia (n  1),
separate normothermic brachiocephalic perfusion with an
anterograde method (n  2), and normothermic cardio-
pulmonary bypass (CPB; n  3; including two patients in
which this procedure was combined with separate normo-
thermic brachiocephalic perfusion).
In group II, the aorta was exposed through a left lateral
thoracic incision (n 20), a midline sternotomy (n 1), a
left lateral sternothoracic incision (n  1), or a thora-
cophrenolumbotomy (n  1). The patients were treated
with aortic cross clamping. The clamp was located either
between the left common carotid and the left subclavian
arteries or on the distal side of the left subclavian artery,
pointing obliquely downwards and to the right. (This
means of clamping obliquely is intended to preserve the
blood flow in as many of the large vessels as possible and
allow for repairs on the largest possible section of the lower
part of the arch). No circulatory arrest was performed. For
spinal cord and visceral protection, common femoral artery
bypass or temporary axillofemoral shunt were used in all
but six patients. Surgical procedures consisted of throm-
bectomy and endarterectomy (n 22), aortic resection and
prosthetic replacement (n  10), and patch aortoplasty
(n  5). In one case, the aortic thrombus disappeared
spontaneously before surgery was performed. In all groups,
eight patients were also treated with vessel reimplantation
or a permanent aorta–left subclavian artery bypass graft. In
one case, a permanent aorta–right carotid artery and right
subclavian artery bypass graft was necessary. Peripheral
embolectomy (n  3), carotid endarterectomy (n  1),
permanent celiac artery–superior mesenteric (n  1), and
abdominal aortobifemoral (n  1) bypass grafts were per-
formed. Preoperative anticoagulation and antiplatelet ther-
apy was given in 71% of the cases (Table II). Thirty-two of
the 38 patients were discharged with a platelet-inhibiting or
anticoagulant medical therapy.
RESULTS
The hospital mortality rate was 2.6%: only one patient
died in the immediate postoperative period. Contact was
lost with four patients after a follow-up period of 12
months. The neurologic complications observed consisted
of two cases of left phrenic nerve paralysis, one case of left
recurrent laryngeal nerve paralysis, one case of increase in
severity of preexisting cerebral defects (dysarthria, dyspho-
nia) with total recuperation after a few months, one case of
vascular accident with minor after effects involving the
vertebrobasilary field (in this case, an axillofemoral bypass
had been performed for distal aortic perfusion during the
surgery), and one case of transient postischemia reperfusion
syndrome. Vascular complications were also observed:
three cases of intermittent claudication in the upper left
limb and one asymptomatic thrombosis of an aorta–left
subclavian artery bypass graft. Finally, we observed one
Subdivision of aorta according to Dubost, Guilmet, and Soyer4
and diagram of case patient distribution between groups I and II.
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Table I. Demographic, clinical, and therapeutic data of patients enrolled in study
Patient
no. Gender
Age
(y) Initial embolic event Pathologic diagnosis
Dubost
classification
1 M 48 Lower limb Atheroma I
2 M 48 Upper limb (multiple) Atheroma I
3 M 48 Upper & lower limbs Thrombus on normal aorta II
4 M 49 Cerebral Atheroma I
5 F 50 Upper limb (unique) Atheroma II
6 F 51 Celiac axis & superior mesenteric arteries Thrombus on normal aorta II
7 M 48 Upper & lower limbs Thrombus on atheroma II
8 M 67 Cerebral (multiple) Atheroma I
9 F 61 Upper & lower limbs Thrombus on atheroma I
10 M 34 Cerebral & upper limb Thrombus on atheroma I
11 F 43 Upper limb Thrombus on atheroma II
12 M 82 Lower limbs (multiple) Thrombus on atheroma II
13 F 58 Upper limb Thrombus on atheroma II
14 M 41 Cerebral & lower limb Thrombus on atheroma I
15 F 61 Lower limb Thrombus on atheroma II
16 F 42 Upper limb Thrombus on normal aorta I
17 M 38 Cerebral & upper limb Atheroma II
18 M 39 Lower limb (multiples) Atheroma II
19 F 42 Upper & lower limbs Atheroma II
20 F 31 Upper limb (multiples) Ectasia of origin of arterial duct II
21 M 58 Upper limb Thrombus on atheroma II
22 F 34 Upper limb (multiples) Thrombus on atheroma II
23 F 36 Lower limb (multiples) Thrombus on fibroblastic plaque II
24 M 43 Superior mesenteric, renal, and lower limb
arteries
Thrombus on atheroma II
25 F 43 Cerebral (multiple) Thrombus on atheroma I
26 M 41 Upper & lower limbs Thrombus on intimal flap II
27 F 69 Upper limb Thrombus on normal aorta II
28 F 65 Hepatic, renal, and lower limb arteries Thrombus on atheroma I
29 M 69 Cerebral Thrombus on atheroma I
30 M 58 Upper & lower limbs Thrombus on atheroma II
31 F 41 Lower limb (multiples) Atheroma II
32 M 56 Cerebral (multiples) & lower limb Atheroma I
33 F 47 Lower limb Atheroma I
34 H 32 Upper & lower limbs & celiac artery Angiosarcoma I
35 F 37 Lower limb Thrombus on normal aorta I
36 F 42 Lower limb Thrombus on normal aorta II
37 M 54 Lower limb (multiples) Thrombus on atheroma II
38 F 62 Upper & lower limbs Thrombus on atheroma II
M, Male; F, female; LSC, left subclavian artery; ICA, internal carotid artery; CFAPB, common femoral artery pump bypass.
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TEE image Operating procedure Circulatory support Other procedures performed
Postoperative course/time
elapsed (mo) since surgery
Protruding Aorto-aortic graft Anterograde cerebroplegia LSC reimplantation No recurrence; 36
Mobile Endarterectomy Profound hypothermia &
retrograde cerebroplegia
None No recurrence; 48
Mobile Thrombectomy None None No recurrence; 38
Protruding Aorto-aortic graft Retrograde cerebroplegia None No recurrence; 24
Mobile Endarterectomy None None No recurrence; upper
limb ischemia; 60
Protruding Thrombectomy Partial CPB Embolectomy in celiac axis
& superior mesenteric
artery
No recurrence; 24
Mobile Endarterectomy &
thrombectomy
None Brachio-ulnar bypass after
1 mo
Recurrence of thrombus
after 6 mo; 36
Sessile Patch aortoplasty Profound hypothermia None No recurrence; transient
aggravation of
neurologic symptoms;
43
Mobile Thrombectomy Profound hypothermia None No new event; 12
Mobile Thrombectomy Profound hypothermia None Recurrence after 6 & 17
mo deceased: multiple
emboli;
Sessile Thrombectomy Partial CPB None No recurrence
Protruding Aorto-aortic graft Partial CPB Transposition of LSC No recurrence; 24
Mobile Aorto-aortic graft None Aorta-LSC bypass No recurrence; 78
Mobile Aorto-aortic graft Profound hypothermia Aorta-LSC bypass No recurrence; 3
Mobile Aorto-aortic graft Partial CPB None Recurrence after 1 mo
(thrombolysis with
heparin) groin
infection; 6
Mobile Absence of thrombus Profound hypothermia None No recurrence; 3
Sessile Patch aortoplasty Axillofemoral shunt None No recurrence; moderate
stroke; 24
Mobile Patch aortoplasty Axillofemoral shunt None No recurrence; 48
Mobile Endarterectomy Axillofemoral shunt None No recurrence; 48
Sessile Patch aortoplasty Axillofemoral shunt Upper limb embolectomy No recurrence; upper
limb ischemia; 24
Mobile Endarterectomy &
thrombectomy
Axillofemoral shunt None No recurrence; upper
limb ischemia; 36
Mobile Thrombectomy Axillofemoral shunt Transposition of right
subclavian artery
No recurrence; 27
Protruding Endarterectomy &
thrombectomy
Axillofemoral shunt None No recurrence; 27
Mobile Endarterectomy &
thrombectomy
Axillofemoral shunt Embolectomy Recurrence after 20 mo
Sessile Right aorto-subclavian
bypass & carotid
bypass
Axillofemoral shunt None No recurrence; cerebral
reperfusion syndrome
Mobile Thrombectomy Partial CPB None No recurrence; 34
Mobile Thrombectomy CPB & separate normothermic
brachiocephalic perfusion
Inferior caval filter No recurrence; 36
Mobile Thrombectomy CPB & separate normothermic
brachiocephalic perfusion
None No recurrence; pleural
hematoma withdrawal;
40
Mobile Aorto-aortic graft CPB & separate normothermic
brachiocephalic perfusion
Large vessel reimplantation No recurrence; 1
Mobile Endarterectomy &
thrombectomy
Axillofemoral shunt Abdominal aorto-bifemoral
bypass
No recurrence; 36
Sessile Endarterectomy None None No recurrence; 82
Not performed Aorto-aortic graft Normothermic CPB Bilateral carotid
endarterectomy
No recurrence; 54
Not performed Patch aortoplasty Profound hypothermia None No recurrence; 54
Normal Aorto-aortic graft Profound hypothermia Celiac axis superior
mesenteric artery bypass
Deceased: multiple
cerebral emboli
Sessile Aorto-aortic graft Profound hypothermia Reimplantation of LSC No recurrence; 16
Mobile Thrombectomy CFAPB & brachiocephalic
artery clamping
None No recurrence; 3
Mobile Thrombectomy None None No recurrence; 6
Protruding Thrombectomy Axillofemoral shunt Reimplantation of LSC No recurrence; 12
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local groin infection on the femoral incision site of a partial
CPB.
All patients received anticoagulant or antiplatelet med-
ical therapy. With an average follow-up time of 30 months
(range, 3 to 82 months), we observed four recurrences, and
each time the thrombus recurred in a different location
(Table III). A double recurrence was observed in one case,
and this patient died after the second episode, 17 months
after surgery. At least three patients had a neurologic deficit
(8%), one of which had no obvious aortic recurrence.
Overall recurrence showed an average term of 8 months
after surgery. In one case, heparin treatment was sufficient
and the patient did not have to undergo another operation.
Histologic analysis results of the pathologic samples
confirmed the presence of an atherosclerotic plaque in 28 of
the 38 cases (73%). In six cases (15%), the aorta appeared
normal. In the four remaining cases, the lesions included an
angiosarcoma, an ectasia located at the insertion of the
remaining segment of the ductus arteriosus, a rupture of
the tunica intima, and a fibroblastic plaque. A thrombus
was present in 26 cases, but in only 17 cases was it related to
an atherosclerotic plaque. In 18 cases, the thrombus was
attached to the arterial wall (with or without a plaque)
behind the insertion of the remains of the ductus arteriosus
in which abnormalities were found in three cases: ectasia
(n  1) and thickening of the arterial wall (n  2). Exam-
ination of mobile lesions (n 22) showed a thrombus in 18
cases and a mobile atherosclerotic plaque in four cases. In
one of the cases, a thrombus was detected twice with two
consecutive TEEs but failed to be confirmed during surgi-
cal exploration of the aorta.
DISCUSSION
The aortic arch is now well recognized as a possible
source of systemic embolism that may complicate athero-
sclerotic plaques.5-8 However, because all reports that doc-
umented a significant association between stroke and pe-
ripheral emboli and the presence of thoracic aortic
atheromas were retrospective, a causal relation cannot be
established.
Two main types of lesion are considered to be potential
sources of emboli: atherosclerotic plaques and aortic arch
thrombosis. Indeed, thrombosis on an apparently normal
aortic arch may nevertheless represent a complication of
underlying atherosclerosis not visible macroscopically. Aor-
tic atherosclerosis may constitute a spectrum of complica-
tions ranging from pure atherosclerotic debris floating in
the aorta (most prevalent in elderly patients) to almost pure
clot formations (often found in younger patients) with
lesions limited to the thrombus insertion site.6 These lim-
ited lesions are not visible on macroscopic examination
after removal of the thrombi. Among the six patients with-
out apparent aortic lesions (patients 3, 6, 16, 27, 35, and
36), only one case (patient 35) was examined histologically,
and no aortic lesion was detected. In the remaining five
patients, no surgical biopsy of the aorta was performed; the
examination was only macroscopic, and so the presence of
microscopic lesion could not be excluded.
Several prospective studies have looked at the risk of
future embolic stroke and peripheral emboli in patients
with protruding atheromas in the thoracic aorta seen on
TEE.8-10 These studies found both an incidence rate of
stroke averaging 12% over a 1-year period and an incidence
rate of all embolic events (stroke and peripheral) of up to
33% in the same short period. In addition, noncalcified
plaques were systematically associated with a higher risk of
embolic vascular events when combined with any of the
other morphologic features, ulceration, or hypoechoic
plaques.11
The main difficulty in establishment of an unequivocal
diagnosis in symptomatic patients is to prove that the lesion
observed in the aortic arch is responsible for the embolic
syndrome. In this respect, currently available investigating
techniques are incapable of detecting the origin of 40% of
cerebral emboli.12 Despite some limitations, TEE is used as
a reference for aortic atherosclerosis quantification, and it
provides useful information about aortic atherosclerosis
and its relationship to cardiovascular clinical events.13 The
aforementioned limitations of TEE explain why it was
combined with another technique, such as magnetic reso-
nance imaging, computed tomography, or digital arterial
angiography (in more than half of the cases in our study: 20
of 38). These tests were not routinely available until re-
cently, which may account for the rarity of their use in the
reports collected for our study.
The medical management of patients with aortic arch
atheromatous disease remains to be defined. Consideration
of the use of anticoagulant therapy and thrombolysis as
logical components of treatment of these patients does
seem reasonable because thrombi have been documented
to develop on and embolize from aortic atheroma. In fact,
thrombi have been noted to disappear during such therapy,
and data from three reports suggest that fewer strokes occur
in the patients who were given warfarin by their physi-
cians.14-16 However, recurrent embolic events may occur
despite anticoagulation therapy in patients who not have
undergone surgical removal of the aortic arch thromboses.
In addition, the “purple toes syndrome” may be a compli-
cation of oral anticoagulant therapy,17 even though the risk
of clinically apparent atheroemboli syndromes during war-
farin therapy appears to be low. Thrombus dissolution
could be performed with intravenous abciximab.18 Combi-
nation of the newer platelet inhibitors and heparin antico-
agulation will have to be evaluated in prospective random-
ized clinical trials. Hydroxymethyl glutaryl coenzyme A
reductase inhibitors could be one possible treatment in
Table II. Preoperative and postoperative medical
treatment undertaken
Preoperative Postoperative
Antiplatelet therapy 4 21
Anticoagulant therapy 23 11
No treatment 11 6
Total patients 38 38
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patients with aortic atherosclerosis. Furthermore, statins
may stabilize plaques and prevent stroke by lipid reduc-
tion.19 They may reduce thrombin generation by platelets,
which is elevated in patients with hypercholesterolemia,20
and statins could also play a role in reducing plaque size in
the aorta.21
Sternal incision was the approach elected for most of
the patients in group I because it allows for the control of
segment 1 and of the large vessels arising from the aortic
arch. It also allows for the separate cannulation of these
vessels and of the coronary arteries when CPB is installed. A
left lateral thoracic incision was preferred for most of the
patients in group II, offering good exposure of segments 2
and 3 and allowing for removal of the lesions located on
most of the lower wall of the arch to be undertaken without
cerebral protection. High-quality preoperative images
must be obtained every time for the most accurate assess-
ment of the extent of the lesions.
The surgical strategies reported in our study confirm
the existing data on aortic arch surgery.22 When cross
clamping of segment 1 or of the proximal part of segment 2
is necessary, it implies circulatory arrest combined with
myocardial and cerebral protection. When the cross clamp
is located beyond the origin of the left common carotid, it
is not always necessary to undertake a circulatory arrest
procedure. On the other hand, long periods of aortic cross
clamping may induce spinal cord ischemia.
Profound hypothermia (n  8 patients, all in group I)
allows excellent myocardial and cerebral protection.23,24
Comparatively, it is a convenient and technically simple
method with a nonencumbered operative field, without
arterial cannulas; also, one can dispense with clamping
when anastomoses are necessary. On the other hand, it is
recommended that the duration of the circulatory arrest
does not exceed 45 to 50 minutes to lower the risk of
cerebral hypoxia and the two classical complications of
profound hypothermia: coagulation disorders with exces-
sive bleeding and pulmonary complications.25 Cooling and
rewarming must be gradual (1° C/min). The duration of
CPB in this technique is comparatively longer. Anterograde
cerebroplegia (n  1 case) allows circulatory arrest to be
maintained for a long period of time and cerebral protec-
tion to be achieved without profound hypothermia.26 It
combines the use of anterograde cardioplegia with a sepa-
rate cerebroplegia carrying hypothermic blood. CPB with a
separate normothermic brachiocephalic perfusion was per-
formed in three other cases. Both methods allow for long
surgical procedures to be undertaken on the aortic arch.
They are inconvenient and complex, necessitating the use
of two sets of cooling equipment and of numerous arterial
cannulas that encumber the operative field. It should be
noted that, regarding cerebral protection, no evidence ex-
ists that these techniques are safer than profound hypother-
mia for operations lasting less than 50 minutes. Retrograde
cerebroplegia (n  2 cases) is used in combination with
profound hypothermia. It represents an improvement over
the isolated use of the latter, permitting surgery for more
than 50 minutes.27 The existence of valves in the internal
jugular veins creates an anatomic difficulty that is usually
easily resolved.28,29 Retrograde cerebroplegia shares the
advantages and inconveniences of profound hypothermia.
Regarding the quality of cerebral protection during circu-
latory arrests lasting less than 50 minutes, no obvious
advantage is seen over the use of profound hypothermia
alone. As regards the complications reputed to be associ-
ated with the use of CPB in profound hypothermia or with
any other means of cerebral protection,22-24 none were
reported in our series. The absence of complications ap-
pears to be related to the fact that the duration of the
circulatory arrest was less than 1 hour in most aortic oper-
ations performed. Whenever surgery is achieved with pro-
found hypothermia alone, the unexpected occurrence of a
technical difficulty can lead to the installation of an addi-
tional retrograde cerebroplegia, thus increasing the possi-
ble duration of the surgical procedure.
In our series, no ischemic neurologic complication was
observed with common femoral artery pump bypass, aortic
cross clamping (as advocated by Crawford, Saleh, and
Schuessler30), and temporary axillofemoral shunt. How-
ever, it should be noted that we do not know the average
Table III. Case report of recurrences
Patient
no.
Dubost
classification
Symptoms of
recurrence
Exploration of
recurrence
Treatment of
recurrence
Postoperative course/
time elapsed (mo) since
recurrence
7 II None TEE Resection & Dacron
graft replacement
No recurrence; 36
10 I Recurring systemic
embolization;
kidneys, upper and
lower limbs, brain
TEE Repeated
thrombectomies
Death in 17 mo
(hemipleagia, cerebral
oedema)
15 II None TEE Heparin Thrombolysis obtained;
no recurrence
24 II Embolisms in: left
lower limb &
superior mesenteric
artery
Computed tomographic
scan, angiography
Ventral aortic bypass No recurrence; 4
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cross-clamping time in our series. Gharagozloo et al31
indicated that with a cross-clamping time longer than 30
minutes the risk of spinal cord ischemia rises from 3% to
11%. They have recommended that additional protective
measures should be used whenever this is the case. The
vascular accident concerning the vertebrobasilary field ob-
served in one case was likely to have been traumatic.
Morbidity and mortality ratios in our study are partic-
ularly low in comparison with other studies concerning
aortic surgery. In the series of Guilmet, Bachet, and Fuzel-
lier32 on aortic arch replacement surgery (Table IV), the
authors specified that these results were unaffected by
either the type of aortic lesions or the circumstances, etiol-
ogy, and duration of the CPB, circulatory arrest, or cerebral
perfusion. The absolute value of our morbidity ratio is
lower than in the study of Guilmet, Bachet, and Fuzellier,32
and we noted no severe complications (cardiac, respiratory,
or neurologic complication). As regards perioperative mor-
tality rate, our ratio was 2.6% and represented only one
patient. The aortic lesion of this patient was confirmed to
have etiology different from those of the other patients.
However, although neuropsychologic deficits are reported
to be frequent sequelae of CPB,33 no cases were mentioned
in either the series of Guilmet, Bachet, and Fuzellier32 or
our study. It is most likely that the good results presented in
our study are related to a combination of a low mean age of
our patients and the rather benign surgical procedures used
because of the localized nature of the lesions. Indeed, the
findings of Guilmet, Bachet, and Fuzellier32 show a strong
association between increased age and increase in perioper-
ative mortality rate (9% under and 27% over 60 years of
age). In their observations, the mortality ratio also varied
according to the site of the surgical repairs, 36% for seg-
ment 3 and 14% when limited to the aortic arch. Lastly, if
we consider the composite incidence rate of negative out-
comes (ie, death, neurologic events, and recurrence of
distal embolization), this was at least 26%, considering that
four patients were not followed.
The possibility of a recurrence of the lesions (n  4
cases) remains a matter of concern. Whenever recurrence
was observed, both the initial and the subsequent lesions
were mobile thrombi developed on an atherosclerotic
plaque. Inversely, atherosclerotic plaques and their projec-
tions were never seen to recur. It was also noted that
recurrence always involved a site different from that of the
initial thrombi, which seems to indicate the presence of
extensive aortic disease. Overall, the recurrence rate in our
series was 12%; it rose to 19% when we considered only
patients who initially had a thrombus. On average, the time
elapsed between surgery and recurrence was 8 months.
This should be taken into consideration when establishing
the duration of the postoperative treatment and follow-up.
In two cases, recurrence was clinically silent, indicating that
a prolonged clinical and echographic follow-up is always
necessary.
In conclusion, the aortic arch frequently bears lesions
that have been retrospectively identified as being likely to
cause embolic events. The source of the embolus is usually
an atherosclerotic plaque or a free-floating thrombus most
often located in the aortic isthmus. Surgery with circulatory
support can be recommended in good operative candidates
with recurrent critical events despite medical management
and with high embolic potential (young patients with no
calcified plaques).
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Hobozit, M. Hoehne, F. Houel, J. M. Jausseran, O. Jega-
den, B. Jegou, J. Jourdan, P. Jue-Denis, Y. Kerdiles, E.
Kieffer, A. Konrat, F. Koskas, J. G. Kretz, M. Lacombe, P.
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siaux, N. Lescoeur, G. Leseche, E. Marcade, H. Mary, P.
Mathieu, J. P. Mazzucotelli, D. Mellie`re, D. Metrad, Cl.
Mialhe, R. Milleret, J. L. Michaud, P. Moreau, P. Nataf, H.
Nicaise, J. B. Nicol, D. Noblet, F. Panes, M. Paquis, Ph.
Pelissier, Ch. Pelleray, G. A. Pelouze, M. Peret, B. Peyce-
lon, Ph. Pinto, J. Pommier, J. L. Poujol, A. Querian, A.
Table IV. Morbidity in series from Guilmet, Bachet, and
Fuzellier32 (130 patients operated on between January
1984 and October 1995)
Morbidity Cases
Neurologic 16
CVA 5
Paraplegia 3
Brown-Sequard syndrome 3
Hemiplegia 3
Transient hemianopia 2
Recurrent laryngeal nerve paralysis 7
Respiratory complications 5
Phrenic nerve paralysis 3
Acute renal failure 3
Mediastinitis 3
Stomach ulcer 1
Myocardal infarction 1
Colonic ischemia 1
Total patients 40/130 (30.76%)
CVA, Cerebrovascular accident.
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